Immunomedics

Immunomedics closes $459m stock offering to launch drug, scale manufacture

04-May-2020 By Ben Hargreaves

April saw the company add new CEO, receive approval for lead ADC drug, and launch a public offering of stock.

Immunomedics adopts PleaseReview to accelerate documentation management

11-Nov-2019 By Vassia Barba

Immunomedics to leverage Ideagen’s PleaseReview software service to support documentation management of its ADC development projects.

Hired and Retired: Spring cleaning

08-Apr-2019 By Ben Hargreaves

As we enter spring, several companies have refreshed the look of their executive boards – some to strengthen their direction and some out of necessity.

FDA observes manipulation of data at Immunomedics facility

14-Feb-2019 By Ben Hargreaves

Following the US FDA issuing a CRL to Immunomedics, the agency has revealed its inspection found instances of data integrity breaches and manipulation.